Our People

William Robinson, MD PhD Clinical Advisor

Dr. Robinson is currently Associate Professor of Medicine in the Division of Immunology and Rheumatology of the Department of Medicine at Stanford University. Dr. Robinson’s laboratory studies autoimmunity. Autoimmune diseases affect 3-5% of the world population, yet the pathogenesis of most autoimmune diseases is unclear. Moreover, current therapies globally modulate immune function, resulting in potentially fatal side effects, and are not curative, serving only to slow disease progression.

At Stanford, he is Director of the Stanford Osteoarthritis Initiative and a co-lead of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network of the NIH. Dr. Robinson was elected to the American Society of Clinical Investigation (ASCI) and serves on the board of directors of Federation of Clinical Immunology Societies (FOCIS).

An active entrepreneur in the immunology space, Dr. Robinson is a co-founder of Atreca and he and his laboratory members invented the technology underlying Atreca’s Immune Repertoire Capture™ technology. He is an inventor on nineteen patent applications, and technologies developed in his Stanford and VA laboratories have been licensed to seven companies in the biotechnology industry. Dr. Robinson was also a co-founder of Bayhill Therapeutics.

Dr. Robinson received his BS, MD, and PhD degrees from Stanford University and completed his clinical training in internal medicine at the University of California, San Francisco.

Back to All